Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,279,063
+$2,866,139 QoQ
Shares Held
256,134
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
6.50%
of 13F equity value
Holder Rank
#140
of 1,348 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Dec 31, 2024CallValue
$1,273,096
CallShares
14,800
PutValue
$1,720,400
PutShares
20,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SALT Holding Corp. holds $52,779,679 across 4 Drug Manufacturers - General names. NVO ranks #3 (23.3% of the industry book) .
All Filings in NVO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,279,063 | 256,134 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $9,412,924 | 256,134 | Shares | Other | 2026-05-15 | |
| 2025-06-30 | $1,703,689 | 24,684 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,776,488 | 39,984 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $1,273,096 | 14,800 | Call | Other | 2025-02-14 | |
| 2024-12-31 | $2,578,105 | 29,971 | Shares | Other | 2025-02-14 | |
| 2024-12-31 | $1,720,400 | 20,000 | Put | Other | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||